Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control.
Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control.
复制标题
黄体生成素释放因子激动剂引起的黄体期缺陷:生育控制模型。
DOI:
10.1126/science.6797068
复制
发表时间:
1982
期刊:
影响因子:
--
通讯作者:
Yen,SS
中科院分区:
文献类型:
--
作者:
Sheehan,KL;Casper,RF;Yen,SS
Subcutaneous injection of 50 micrograms of a luteinizing hormone-releasing factor agonist (LRF agonist) for three successive days at the time of menstruation in normal cycling women induces a shortened luteal phase with suboptimal concentrations of circulating estradiol and progesterone. This luteal phase defect follows a reduced concentration of follicle-stimulating hormone during the follicular phase and a resulting inadequate follicular maturation. Since a short luteal phase is associated with an endometrium not conducive to implantation, administration of the LRF agonist at the onset of menstrual cycle may prove to be a practical and novel approach to fertility control.